Literature DB >> 16840358

Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells.

Josh A Noser1, Greg J Towers, Ryuta Sakuma, Jean-Maurice Dumont, Mary K L Collins, Yasuhiro Ikeda.   

Abstract

Murine primary cells are poorly permissive to human immunodeficiency virus type 1 (HIV-1) vector infection. Retroviral infectivity is influenced by dominant inhibitors such as TRIM5alpha. Sensitivity to TRIM5alpha is altered by interactions between cyclophilin A and the HIV-1 capsid. Here we demonstrate that competitive inhibitors of cyclophilins, cyclosporine or the related Debio-025, stimulate HIV-1 vector transduction of primary murine cells, including bone marrow and macrophages, up to 20-fold. Unexpectedly, the infectivity of an HIV-1 mutant or a simian lentivirus that does not recruit cyclophilin A is also stimulated by these drugs. We propose that cyclosporine and related compounds will be useful tools for experimental infection of murine primary cells. It is possible that HIV-1 infection of murine cells is inhibited by dominant factors related to immunophilins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840358      PMCID: PMC1563702          DOI: 10.1128/JVI.02427-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Gene transduction efficiency in cells of different species by HIV and EIAV vectors.

Authors:  Y Ikeda; M K L Collins; P A Radcliffe; K A Mitrophanous; Y Takeuchi
Journal:  Gene Ther       Date:  2002-07       Impact factor: 5.250

3.  Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.

Authors:  Neeltje A Kootstra; Carsten Munk; Nina Tonnu; Nathaniel R Landau; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

4.  Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells.

Authors:  Christopher M Owens; Peter C Yang; Heinrich Göttlinger; Joseph Sodroski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Species-specific, postentry barriers to primate immunodeficiency virus infection.

Authors:  W Hofmann; D Schubert; J LaBonte; L Munson; S Gibson; J Scammell; P Ferrigno; J Sodroski
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells.

Authors:  Udayan Chatterji; Michael D Bobardt; Robyn Stanfield; Roger G Ptak; Luke A Pallansch; Priscilla A Ward; Maureen J Jones; Cheryl A Stoddart; Pietro Scalfaro; Jean-Maurice Dumont; Kamel Besseghir; Brigitte Rosenwirth; Philippe A Gallay
Journal:  J Biol Chem       Date:  2005-09-30       Impact factor: 5.157

7.  A dominant block to HIV-1 replication at reverse transcription in simian cells.

Authors:  Carsten Münk; Stephanie M Brandt; Ginger Lucero; Nathaniel R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

8.  Restriction of multiple divergent retroviruses by Lv1 and Ref1.

Authors:  Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Paul D Bieniasz; Greg J Towers
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

9.  Restriction of lentivirus in monkeys.

Authors:  Caroline Besnier; Yasuhiro Takeuchi; Greg Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

10.  Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.

Authors:  Simone Cowan; Theodora Hatziioannou; Tshaka Cunningham; Mark A Muesing; Heinrich G Gottlinger; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

View more
  22 in total

1.  Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Authors:  Ryuta Sakuma; Amber A Mael; Yasuhiro Ikeda
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

2.  Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane.

Authors:  Seiga Ohmine; Raman Deep Singh; David L Marks; Melissa A Meyer; Richard E Pagano; Yasuhiro Ikeda
Journal:  J Innate Immun       Date:  2013-03-21       Impact factor: 7.349

3.  Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.

Authors:  Seiga Ohmine; Ryuta Sakuma; Toshie Sakuma; Tayaramma Thatava; Gonzalo P Solis; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

4.  Xenotropic murine leukemia virus-related virus is susceptible to AZT.

Authors:  Ryuta Sakuma; Toshie Sakuma; Seiga Ohmine; Robert H Silverman; Yasuhiro Ikeda
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

5.  Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.

Authors:  Ianko D Iankov; Pavlos Msaouel; Cory Allen; Mark J Federspiel; Peggy A Bulur; Allan B Dietz; Dennis Gastineau; Yasuhiro Ikeda; James N Ingle; Stephen J Russell; Evanthia Galanis
Journal:  Breast Cancer Res Treat       Date:  2009-11-06       Impact factor: 4.872

6.  Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.

Authors:  Miguel G Toscano; Mario Delgado; Weimin Kong; Francisco Martin; Mario Skarica; Doina Ganea
Journal:  Mol Ther       Date:  2010-01-12       Impact factor: 11.454

7.  Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells.

Authors:  David M Ricks; Robert Kutner; Xian-Yang Zhang; David A Welsh; Jakob Reiser
Journal:  Stem Cells Dev       Date:  2008-06       Impact factor: 3.272

8.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Authors:  J Reutenauer; O M Dorchies; O Patthey-Vuadens; G Vuagniaux; U T Ruegg
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

9.  Induced pluripotent reprogramming from promiscuous human stemness related factors.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Amber A Mael; Andre Terzic; Yasuhiro Ikeda
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

10.  Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells.

Authors:  Carolina Petrillo; Daniela Cesana; Francesco Piras; Sara Bartolaccini; Luigi Naldini; Eugenio Montini; Anna Kajaste-Rudnitski
Journal:  Mol Ther       Date:  2014-10-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.